Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.41 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6002444 | 0.94 | TSHR (0.47) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL8915435 | 0.93 | TSHR (0.49) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL20526214 | 0.93 | TSHR (0.49) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL27521423 | 0.93 | TSHR (0.49) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL29575676 | 0.91 | TSHR (0.47) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL30528958 | 0.91 | TSHR (0.47) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL11286528 | 0.88 | LMNA (0.46) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL28316278 | 0.86 | LMNA (0.44) | TSHRTDP1L3MBTL1LTA4HSMN1; SMN2 | |
| SCHEMBL6744587 | 0.83 | RECQL (0.47) | TSHRTDP1L3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL1846993 | 0.81 | CYP24A1 (0.41) | TDP1L3MBTL1CYP24A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10930872-B2 | Light-emitting electrochemical cell, composition for forming light-emitting layer of light-emitting electrochemical cell, and ionic compound for light-emitting layer of light-emitting electrochemical cell | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2021-02-23 | — | — | US | disclosed |
| US-20180301653-A1 | LIGHT-EMITTING ELECTROCHEMICAL CELL, COMPOSITION FOR FORMING LIGHT-EMITTING LAYER OF LIGHT-EMITTING ELECTROCHEMICAL CELL, AND IONIC COMPOUND FOR LIGHT-EMITTING LAYER OF LIGHT-EMITTING ELECTROCHEMICAL CELL | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2018-10-18 | — | — | US | disclosed |
| EP-3386274-A1 | ELECTROCHEMICAL LIGHT EMITTING CELL, COMPOSITION FOR FORMING LIGHT EMITTING LAYER OF ELECTROCHEMICAL LIGHT EMITTING CELL, AND IONIC COMPOUND FOR LIGHT EMITTING LAYER OF ELECTROCHEMICAL LIGHT EMITTING CELL | Nippon Chemical Industrial Co., Ltd. (JP) | 2018-10-10 | — | — | EP | disclosed |
| CN-108293284-A | The luminescent layer ionic compound of electrochemical luminescence unit, the luminescent layer formation composition of electrochemical luminescence unit and electrochemical luminescence unit | 日本化学工业株式会社 | 2018-07-17 | — | — | CN | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10930872-B2 | Light-emitting electrochemical cell, composition for forming light-emitting layer of light-emitting electrochemical cell, and ionic compound for light-emitting layer of light-emitting electrochemical cell | CRY2, CRY1, L1CAM | TSHR 2939/4885TDP1 2826/4885L3MBTL1 1990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.